Skip to main content Accessibility help
×
Home

Is adjunctive CBT really effective for schizophrenia?: COMMENTARY ON… COCHRANE CORNER

  • Katherine Reid (a1)

Summary

Although antipsychotic medication remains the mainstay of treatment for schizophrenia, medications alone are not always successful. Cognitive–behavioural therapy (CBT) is recommended as an adjunct to pharmacological treatment. The Cochrane review under consideration evaluates the effects of offering CBT as an add-on to standard care compared with standard care alone, and this commentary puts those findings into their clinical context.

DECLARATION OF INTEREST

None.

Copyright

Corresponding author

Correspondence Dr Katherine Reid, Warneford Hospital, Warneford Lane, Headington, Oxford OX3 3JX, UK. Email: katherine.reid@psych.ox.ac.uk

Footnotes

Hide All

See this issue.

Footnotes

References

Hide All
Barrowclough, C, Haddock, G, Tarrier, N, et al. (2001) Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158: 1706–13.
Barrowclough, C, Haddock, G, Wykes, T, et al. (2010) Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ (Clinical Research Edn), 341: c6325.
Barrowclough, C, Marshall, M, Gregg, L, et al. (2014) A phase-specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine, 44: 2749–61.
Burns, T (2009) End of the road for treatment-as-usual studies? British Journal of Psychiatry, 195: 56.
Cao, J, Zhu, J, Xu, L, et al. (2014) Study on the effects of cognitive-behavioral intervention on the rehabilitation of first-episode schizophrenia. Journal of Psychiatry, 27: 297–9.
D'Agostino, A, Rossi Monti, M, Starcevic, V (2019) Psychotic symptoms in borderline personality disorder: an update. Current Opinion in Psychiatry, 32: 2226.
Freedland, KE, Mohr, DC, Davidson, KW, et al. (2011) Usual and unusual care: existing practice control groups in randomized controlled trials of behavioural interventions. Psychosomatic Medicine, 73: 323–35.
Gleeson, JFM, Cotton, SM, Alvarez-Jimenez, M, et al. (2009) A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. Journal of Clinical Psychiatry, 70: 477–86.
Grawe, RW, Falloon, IR, Widen, JH, et al. (2006) Two years of continued early treatment for recent-onset schizophrenia: a randomised controlled study. Acta Psychiatrica Scandinavica, 114: 328–36.
Gumley, A, O'Grady, M, McNay, L, et al. (2003) Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine, 33: 419–31.
He, X, Li, Z, Chen, Y (2012) Efficacy of cognitive behavioral therapy for anxiety in females with first-episode paranoid schizophrenia. Medical Journal of Chinese People's Health, 24: 651–3.
Higgins, JPT, Green, S (eds) (2011) Part 2: General methods for Cochrane reviews. In Cochrane Handbook for Systematic Reviews of Interventions: Version 5.1.0. Cochrane Collaboration.
Horvath, AO, Symonds, BD (1991) Relation between working alliance and outcome in psychotherapy: a meta-analysis. Journal of Counseling Psychology, 38: 139–49.
Jones, C, Hacker, D, Xia, J, et al. (2018a) Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia. Cochrane Database of Systematic Reviews, 12: CD007964 (doi: 10.1002/14651858.CD007964.pub2).
Jones, C, Hacker, D, Meaden, A, et al. (2018b) Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia. Cochrane Database of Systematic Reviews, 11: CD008712 (doi: 10.1002/ 14651858.CD008712.pub3).
Karver, MS, Handelsman, JB, Fields, S, et al. (2006) Meta-analysis of therapeutic relationship variables in youth and family therapy: the evidence for different relationship variables in the child and adolescent treatment outcome literature. Clinical Psychology Review, 26: 5065.
Kingdon, DG, Ashcroft, K, Bhandari, B, et al. (2010) Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood trauma. Journal of Nervous and Mental Disease, 198: 399403.
Kuipers, E, Garety, P, Fowler, D, et al. (1997) London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I: Effects of treatment phase. British Journal of Psychiatry, 171: 319–27.
Lehman, ALJ, Dixon, L (2004) APA practice guidelines: Schizophrenia. American Journal of Psychiatry, 161(Suppl 2): 156.
Li, X, Guo, Y, Fu, C, et al. (2014) Clinical efficiency and safety of CBT combined with low-dose risperidone alliance treatment on auditory hallucination in schizophrenia patients. Sichuan Mental Health, 27: 502–4.
Martin, DJ, Garske, JP, Davis, MK (2000) Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. Journal of Consulting and Clinical Psychology, 68: 438–50.
Naeem, F, Farooq, S, Kingdon, D (2015) Cognitive behavioural therapy (brief versus standard duration) for schizophrenia. Cochrane Database of Systematic Reviews, 10: CD010646 (doi: 10.1002/14651858.CD010646.pub3).
National Institute for Health and Care Excellence (2014) 1 Recommendations. In Psychosis and Schizophrenia in Adults: Prevention and Management (Clinical Guideline CG178). NICE.
Pan, S (2012) Cognitive therapy in the care of schizophrenic depression. Xin Li Yisheng, 7: 206–7.
Royal College of Psychiatrists (2018) National Clinical Audit of Psychosis: National Report for the Core Audit 2018. Healthcare Quality Improvement Partnership.
Schermuly-Haupt, M-L, Linden, M, Rush, AJ (2018) Unwanted events and side effects in cognitive behavior therapy. Cognitive Therapy and Research, 42: 219–29.
Schünemann, H, Brożek, J, Guyatt, G, et al. (2013) GRADE Handbook. GRADE.
Sibbald, B, Roberts, C (1998) Understanding controlled trials: crossover trials. BMJ, 316: 1719.
Startup, M, Jackson, MC, Startup, S (2004) Insight and recovery from acute psychotic episodes: the effects of cognitive behavior therapy and premature termination of treatment. Journal of Nervous and Mental Disease, 194: 740–50.
Tenny, S, Hoffman, MR (2019) Relative Risk. STATPearls Knowledge Base/StatPearls Publishing (http://knowledge.statpearls.com/chapter/nurse-calculations/28324). Accessed 23 April 2019.
Wang, Z, Guo, Z, Han, G, et al. (2015) Efficacy of cognitive-behavioral therapy in community schizophrenia patients. China Journal of Health Psychology, 23: 16–9.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Is adjunctive CBT really effective for schizophrenia?: COMMENTARY ON… COCHRANE CORNER

  • Katherine Reid (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *